Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,397 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment Outcomes of Head and Neck Cancer Patients in the Elderly Receiving Different Chemoradiation Combinations: A Single-Center Experience.
Karivedu V, Bonomi M, Issa M, Blakaj A, Klamer BG, Pan X, Old M, Bhateja P, Kang S, Seim N, Ozer E, Agrawal A, Mitchell D, Gamez ME, Grecula J, Jhawar SR, Baliga S, Carrau RL, Rocco J, Blakaj D. Karivedu V, et al. Among authors: mitchell d. Oncol Res Treat. 2021;44(10):521-529. doi: 10.1159/000518548. Epub 2021 Aug 17. Oncol Res Treat. 2021. PMID: 34515190
Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma.
Barney CL, Walston S, Zamora P, Healy EH, Nolan N, Diavolitsis VM, Neki A, Rupert R, Savvides P, Agrawal A, Old M, Ozer E, Carrau R, Kang S, Rocco J, Teknos T, Grecula JC, Wobb J, Mitchell D, Blakaj D, Bhatt AD. Barney CL, et al. Among authors: mitchell d. Oral Oncol. 2018 Apr;79:9-14. doi: 10.1016/j.oraloncology.2018.02.001. Epub 2018 Feb 12. Oral Oncol. 2018. PMID: 29598954
Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer.
Beckham TH, Barney C, Healy E, Wolfe AR, Branstetter A, Yaney A, Riaz N, McBride SM, Tsai CJ, Kang J, Yu Y, Chen L, Sherman E, Dunn L, Pfister DG, Tan J, Rupert R, Bonomi M, Zhang Z, Lobaugh SM, Grecula JC, Mitchell DL, Wobb JL, Miller ED, Blakaj DM, Diavolitsis VM, Lee N, Bhatt AD. Beckham TH, et al. Among authors: mitchell dl. Int J Cancer. 2020 Jul 1;147(1):107-115. doi: 10.1002/ijc.32736. Epub 2019 Nov 11. Int J Cancer. 2020. PMID: 31609479
Primary vs nodal site PET/CT response as a prognostic marker in oropharyngeal squamous cell carcinoma treated with intensity-modulated radiation therapy.
Eckstein JM, Nolan N, Healy E, Wright CL, Jain A, Barney CL, Washington I, McElroy JP, Grecula JC, Wobb JL, Mitchell DL, Miller E, Gamez M, Blakaj D, Diavolitsis V, Bhatt A. Eckstein JM, et al. Among authors: mitchell dl. Head Neck. 2020 Sep;42(9):2405-2413. doi: 10.1002/hed.26242. Epub 2020 May 11. Head Neck. 2020. PMID: 32391626
A predictive survival model for patients with head and neck squamous cell carcinoma treated with immune check point inhibitors.
Bonomi M, Bhateja P, Issa M, Klamer B, Pan X, Blakaj A, Karivedu V, Mousa L, Mitchell D, Gamez M, Kang S, Seim NB, Old M, Carrau R, Rocco J, Blakaj D. Bonomi M, et al. Among authors: mitchell d. Oral Oncol. 2020 Nov;110:104900. doi: 10.1016/j.oraloncology.2020.104900. Epub 2020 Jul 20. Oral Oncol. 2020. PMID: 32702630 Free article.
Identification of Clinical and Socioeconomic Predictors of Adjuvant Therapy after Trans-Oral Robotic Surgery in Patients with Oropharyngeal Squamous Cell Carcinoma.
Baliga S, Klamer B, Jhawar S, Gamez M, Mitchell D, Blakaj A, Grecula J, Gardner U, Dibs K, Old M, Seim N, Kang S, Carrau R, Agrawal A, Karivedu V, Bhateja P, Ozer E, Rocco J, Bonomi M, Blakaj D. Baliga S, et al. Among authors: mitchell d. Cancers (Basel). 2020 Sep 1;12(9):2474. doi: 10.3390/cancers12092474. Cancers (Basel). 2020. PMID: 32882857 Free PMC article.
Thyroid-optimized and thyroid-sparing radiotherapy in oral cavity and oropharyngeal carcinoma: A dosimetric study.
Wu AK, Damico NJ, Healy E, Kharouta MZ, Khandel G, Deshane A, Sipos J, Eckstein J, Zoller W, Ewing A, Ling S, Wobb J, Mitchell D, Grecula J, Jhawar S, Miller E, Gamez M, Diavolitsis V, Blakaj D, Bhatt AD. Wu AK, et al. Among authors: mitchell d. Tech Innov Patient Support Radiat Oncol. 2021 Nov 1;20:28-34. doi: 10.1016/j.tipsro.2021.10.003. eCollection 2021 Dec. Tech Innov Patient Support Radiat Oncol. 2021. PMID: 34765751 Free PMC article.
Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort.
Issa M, Klamer BG, Mladkova N, Laliotis GI, Karivedu V, Bhateja P, Byington C, Dibs K, Pan X, Chakravarti A, Grecula J, Jhawar SR, Mitchell D, Baliga S, Old M, Carrau RL, Rocco JW, Blakaj DM, Bonomi M. Issa M, et al. Among authors: mitchell d. BMC Cancer. 2022 Jul 14;22(1):767. doi: 10.1186/s12885-022-09809-5. BMC Cancer. 2022. PMID: 35836204 Free PMC article.
4,397 results